234 related articles for article (PubMed ID: 23267797)
1. Rosiglitazone treatment does not decrease amyloid deposition in transplanted islets from transgenic mice expressing human islet amyloid polypeptide.
Udayasankar J; Zraika S; Aston-Mourney K; Subramanian SL; Brooks-Worrell BM; Taborsky GJ; Hull RL
Transplant Proc; 2013 Mar; 45(2):574-9. PubMed ID: 23267797
[TBL] [Abstract][Full Text] [Related]
2. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets.
Udayasankar J; Kodama K; Hull RL; Zraika S; Aston-Mourney K; Subramanian SL; Tong J; Faulenbach MV; Vidal J; Kahn SE
Diabetologia; 2009 Jan; 52(1):145-53. PubMed ID: 19002432
[TBL] [Abstract][Full Text] [Related]
3. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
4. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice.
Westermark G; Westermark P; Eizirik DL; Hellerström C; Fox N; Steiner DF; Andersson A
Metabolism; 1999 Apr; 48(4):448-54. PubMed ID: 10206436
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide.
Hull RL; Shen ZP; Watts MR; Kodama K; Carr DB; Utzschneider KM; Zraika S; Wang F; Kahn SE
Diabetes; 2005 Jul; 54(7):2235-44. PubMed ID: 15983227
[TBL] [Abstract][Full Text] [Related]
6. Enhancing islet engraftment with rosiglitazone.
Hsu BR; Fu SH; Ku KW; Yang TY; Juang JH; Chen ST
Transplant Proc; 2005; 37(1):245-7. PubMed ID: 15808609
[TBL] [Abstract][Full Text] [Related]
7. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
[TBL] [Abstract][Full Text] [Related]
8. Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice.
Aitken JF; Loomes KM; Riba-Garcia I; Unwin RD; Prijic G; Phillips AS; Phillips ARJ; Wu D; Poppitt SD; Ding K; Barran PE; Dowsey AW; Cooper GJS
Biochem Biophys Res Commun; 2017 Jan; 482(4):625-631. PubMed ID: 27865831
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model.
Liu C; Koeberlein B; Feldman MD; Mueller R; Wang Z; Li Y; Lane K; Hoyt CC; Tomaszewski JE; Naji A; Rickels MR
Endocrinology; 2012 Apr; 153(4):1673-83. PubMed ID: 22355065
[TBL] [Abstract][Full Text] [Related]
11. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
[TBL] [Abstract][Full Text] [Related]
12. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice.
Pepper AR; Bruni A; Pawlick R; Wink J; Rafiei Y; Gala-Lopez B; Bral M; Abualhassan N; Kin T; Shapiro AMJ
Transplantation; 2017 Oct; 101(10):2321-2329. PubMed ID: 28072753
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.
Hull RL; Zraika S; Udayasankar J; Kisilevsky R; Szarek WA; Wight TN; Kahn SE
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1586-93. PubMed ID: 17804609
[TBL] [Abstract][Full Text] [Related]
14. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.
Hull RL; Andrikopoulos S; Verchere CB; Vidal J; Wang F; Cnop M; Prigeon RL; Kahn SE
Diabetes; 2003 Feb; 52(2):372-9. PubMed ID: 12540610
[TBL] [Abstract][Full Text] [Related]
15. Extensive amyloid formation in transplanted microencapsulated mouse and human islets.
Bohman S; Westermark GT
Amyloid; 2012 Jun; 19(2):87-93. PubMed ID: 22587435
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
Aston-Mourney K; Zraika S; Udayasankar J; Subramanian SL; Green PS; Kahn SE; Hull RL
J Biol Chem; 2013 Feb; 288(5):3553-9. PubMed ID: 23229548
[TBL] [Abstract][Full Text] [Related]
17. Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase.
Potter KJ; Werner I; Denroche HC; Montane J; Plesner A; Chen Y; Lei D; Soukhatcheva G; Warnock GL; Oberholzer J; Fraser PE; Verchere CB
Am J Transplant; 2015 Jun; 15(6):1519-30. PubMed ID: 25833002
[TBL] [Abstract][Full Text] [Related]
18. cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.
Subramanian SL; Hull RL; Zraika S; Aston-Mourney K; Udayasankar J; Kahn SE
Diabetologia; 2012 Jan; 55(1):166-74. PubMed ID: 22038516
[TBL] [Abstract][Full Text] [Related]
19. Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice.
Lee EM; Park I; Lee YJ; You YH; Kim JW; Kim MJ; Ahn YB; Kim P; Ko SH
Islets; 2018 Jan; 10(1):25-39. PubMed ID: 29333922
[TBL] [Abstract][Full Text] [Related]
20. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
